<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318511</url>
  </required_header>
  <id_info>
    <org_study_id>RD2014-10-04</org_study_id>
    <nct_id>NCT02318511</nct_id>
  </id_info>
  <brief_title>An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis</brief_title>
  <official_title>An Investigation of ReNu™ Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NuTech Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NuTech Medical, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Prospective, Randomized study evaluating the efficacy of ReNu for the treatment of
      Kellgren-Lawrence grade 2 or 3 osteoarthritis. Patients will be randomized into 1 of 3 groups
      for injection into the effected knee: 1) ReNu - study treatment, 2) Hyaluronic Acid (HA)
      injection - with commonly used injection material and 3) Saline. After treatment, patients
      will be followed up to 12 months to evaluate improvements using common pain and function
      subscales.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS Pain Scale Change from Baseline</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>VAS Pain Scale Change from Baseline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>KOOS Pain and Function Subscales Change from Baseline</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>KOOS Pain and Function Subscales Change from Baseline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>KOOS Pain and Function Subscales change from Baseline</measure>
    <time_frame>1 week, 6 weeks, 3 months, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other patient reported outcomes (PROs) change from Baseline</measure>
    <time_frame>1 week, 6 week, 3 months, 6 months, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic (X-ray) measurement of standing joint space change from Baseline</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>ReNu amniotic allograft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Knee injection with ReNu. ReNu is an allograft tissue composed of particularized amniotic membrane and cell from the amniotic fluid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Knee injection with saline. Injectable saline will be used as the placebo control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HA injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Knee injection with HA. HA will be used as a viscosupplementation injection consisting of cross linked HA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Knee injection</intervention_name>
    <description>Injection into knee for the treatment of Osteoarthritis</description>
    <arm_group_label>ReNu amniotic allograft</arm_group_label>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_label>HA injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReNu amniotic allograft</intervention_name>
    <arm_group_label>ReNu amniotic allograft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>placebo saline</intervention_name>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic Acid</intervention_name>
    <arm_group_label>HA injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with moderate knee osteoarthritis determined by a combination of clinical and
             radiographic findings and documented by Kellgren-Lawrence radiographic classification
             (Grade 2 or 3)

          -  Grade 2 Kellgren-Lawrence radiographic changes are defined as small osteophytes,
             possible narrowing of joint space

          -  Grade 3 Kellgren-Lawrence radiographic changes are defined as moderate multiple
             osteophytes, definite narrowing of joints space, some sclerosis and possible deformity
             of bone contour.

          -  Patients with bilateral grade 2 or 3 Kellgren Lawrence knee osteoarthritis who have
             bilateral symptoms may have their more symptomatic knee injected. If equivalent
             symptoms are reported by the patient, then the patient will choose which knee is to be
             injected. The contralateral knee can be treated with local standard of care such as
             steroid injection, cold therapy or soft brace.

          -  Age 18 and older

          -  BMI less than 40

          -  7 day average pain score of 4 or greater for the involved knee on a numeric pain scale
             from 1 to 10.

          -  Female patients must be actively practicing a contraception method, abstinence, be
             surgically sterilized, or be postmenopausal

        Exclusion Criteria:

          -  Pain medication (including nonsteroidal antiinflammatory drugs, NSAIDs) less than 15
             days before injection (may take acetaminophen)

          -  Receiving pain medication other than acetaminophen for conditions unrelated to
             osteoarthritis of the index knee

          -  Regular use of anticoagulants, such as Coumadin, dabigatran or rivaroxaban; use of
             antiplatelet medications are not a reason for exclusion

          -  History of substance abuse.

          -  Failure to agree NOT to take additional knee symptom modifying drugs, other than
             acetaminophen, during the course of the study without reporting to the study team

          -  Pregnancy or desire to become pregnant during study duration

          -  Positive pregnancy test on premenopausal subject

          -  Morbid obesity (defined as BMI 40 or greater)

          -  Symptoms of locking, intermittent block to range of motion or loose body sensation
             which could indicate meniscal displacement or an intraarticular loose body

          -  Corticosteroid injection into the index knee within 3 months

          -  Viscosupplement injection into the index knee within 3 months

          -  Knee surgery of involved index knee within 12 months

          -  Knee surgery contralateral knee 6 months

          -  Worker compensation

          -  Acute index knee injury (injury within 3 months)

          -  History of Diabetes mellitus

          -  History of solid organ or hematologic transplantation

          -  History of rheumatoid arthritis or other autoimmune disorder

          -  Diagnosis of a non-basal cell malignancy within the preceding 5 years

          -  Infection requiring antibiotic treatment within the preceding 3 months

          -  Current therapy with any immunosuppressive medication, including corticosteroids at a
             dose &gt; 5 mg per day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jack Farr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OrthoIndy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>American Sports Medicine Institute</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Orthopedics at Rush, LLC</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthoindy</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Clinical and Translational Science UK Chandler Medical Center, Pavilion H</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536-2093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Missouri Orthopaedic Institute (MOI)</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Orthopaedics</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Orthopedics</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

